REFERENCES
- Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the manage-ment of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.
- Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: rec-ommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.
- Mease PJ. Improving the routine management of rheumatoid arthritis: the value of tight control. J Rheumatol. 2010;37:1570–8.
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthr Rheum. 2010;62: 2569–81.
- Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69: 1580–8.
- Tamai M, Kawakami K, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrist and finger joints and serologic autoantibodies. Arthr Rheum. 2009;61:772–8.
- Hodgson RJ, O'Connor P, Moots R. MRI of rheumatoid arthri-tis-image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology. 2008;47: 13–21.
- Ostergaard M, Pedersen SJ, DOhn UM. Imaging in rheumatoid arthritis-status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conven-tional radiography. Best Pract Res Clin Rheumatol. 2008;22: 1019–44.
- Hetland M, Ejbjerg B, Horslev-Petersen K, Jacobsen S, Vest-ergaard A, Junk AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheu-matoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009;68: 384–90.
- Hetland M, Stengaard-Pedersen K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al. Radiographic progression and remission rates in early rheumatoid arthritis-MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis. 2010;69:1789–95.
- Kita J, Tamai M, Arima K, Nakashima Y, Suzuki T, Kawashiri S, et al. Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration. Mod Rheumatol. 2011.
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 1988;31:315–24.
- Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Fujikawa K, et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheu-matoid arthritis. J Rheumatol. 2007;34:2154–7.
- Tamai M, Kawakami A, Iwamoto N, Kawashiri SY, Fujikawa K, Aramaki T, et al. Comparative study of the detection of joint injury in early-stage rheumatoid arthritis by MRI of wrist and finger joints and physical examination. Arthritis Care Res. 2011;63:436–9.
- Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21:663–75.
- Sakai R, Komano Y, Tanaka M, Nanki T, Koike R, Nakajima A, et al. The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis. Mod Rheumatol. 2011;21:444–8.
- Salaffi F, Carotti M, Ciapetti A, Gasparini S, Filippucci E, Grassi W. Relationship between time-integrated disease activity esti-mated by DA528-CRP and radiographic progression of anatom-ical damage in patients with early rheumatoid arthritis. BMC Musculoskelet Disord. 2011;12:120.
- Haavardsholm EA, Ostergaard M, Hammer HB, Boyesen P, Boonen A, van der Heijde D, et al. Monitoring anti-TNFa treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage. Ann Rheum Dis. 2009;68:1572–9.
- Emery P, Durez P, Dougados M, Legerton CW, Becker J-C, Vratsanos G, et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis. 2010;69:510–6.
- Schett G. Bone marrow edema. Ann N Y Acad Sci. 2009;1154: 35–40.